Immix Biopharma (IMMX) Earnings Date & Reports

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMMX is expected to report earnings to rise 40.00% to -20 cents per share on September 03

Immix Biopharma IMMX Stock Earnings Reports

Q2'25

Est.

$-0.21

Q1'25

Beat

by $0.08

Q4'24

Est.

$-0.25

Q3'24

Missed

by $0.08

Q2'24

Est.

$-0.15

The last earnings report on May 28 showed earnings per share of -15 cents, beating the estimate of -23 cents. With 576.47K shares outstanding, the current market capitalization sits at 57.43M.

View a ticker or compare two or three

Compare

IMMX